These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 30669140)
21. Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database. Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Luigetti M; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Beghi E; Liberatore G; Santoro L; Peci E; Tronci S; Cotti Piccinelli S; Toscano A; Piccolo L; Verrengia EP; Leonardi L; Schirinzi E; Mataluni G; Ruiz M; Dacci P; Nobile-Orazio E; Eur J Neurol; 2020 Jan; 27(1):136-143. PubMed ID: 31325350 [TBL] [Abstract][Full Text] [Related]
22. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review. Rzepiński Ł; Doneddu PE; Cutellè C; Zawadka-Kunikowska M; Nobile-Orazio E Neurol Sci; 2023 Sep; 44(9):3071-3082. PubMed ID: 37083958 [TBL] [Abstract][Full Text] [Related]
23. Outcome in chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis. Al-Zuhairy A; Jakobsen J Muscle Nerve; 2023 Oct; 68(4):388-396. PubMed ID: 36928889 [TBL] [Abstract][Full Text] [Related]
24. Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy. French CIDP Study Group J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):115-8. PubMed ID: 18202204 [TBL] [Abstract][Full Text] [Related]
25. Clinical Characteristics and Treatment Response of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Suanprasert N; Hanchaiphiboolkul S J Med Assoc Thai; 2017 Mar; 100(3):262-9. PubMed ID: 29911781 [TBL] [Abstract][Full Text] [Related]
26. Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs. Darbà J; Marsà A Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):665-670. PubMed ID: 34720023 [TBL] [Abstract][Full Text] [Related]
27. Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database. Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Mazzeo A; Marfia GA; Cortese A; Fierro B; Jann S; Beghi E; Clerici AM; Carpo M; Schenone A; Luigetti M; Lauria G; Antonini G; Rosso T; Siciliano G; Cavaletti G; Liberatore G; Santoro L; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Toscano A; Mataluni G; Piccolo L; Cosentino G; Sabatelli M; Nobile-Orazio E; J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):125-132. PubMed ID: 30297520 [TBL] [Abstract][Full Text] [Related]
28. Clinical factors, diagnostic delay, and residual deficits in chronic inflammatory demyelinating polyradiculoneuropathy. Bunschoten C; Blomkwist-Markens PH; Horemans A; van Doorn PA; Jacobs BC J Peripher Nerv Syst; 2019 Sep; 24(3):253-259. PubMed ID: 31410938 [TBL] [Abstract][Full Text] [Related]
29. Research criteria for defining patients with CIDP. Sander HW; Latov N Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417 [TBL] [Abstract][Full Text] [Related]
30. Chronic neuropathies - chronic inflammatory demyelinating neuropathy and its variants. Ramchandren S; Lewis RA Front Neurol Neurosci; 2009; 26():12-25. PubMed ID: 19349703 [TBL] [Abstract][Full Text] [Related]
31. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. Nobile-Orazio E J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201 [TBL] [Abstract][Full Text] [Related]
32. A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy. Léger JM Expert Opin Pharmacother; 2005 Apr; 6(4):569-82. PubMed ID: 15934883 [TBL] [Abstract][Full Text] [Related]
34. Management strategies in chronic inflammatory demyelinating polyradiculoneuropathy. Patel K; Bhanushali M; Muley SA Neurol India; 2010; 58(3):351-60. PubMed ID: 20644261 [TBL] [Abstract][Full Text] [Related]
35. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Hughes RA; Bouche P; Cornblath DR; Evers E; Hadden RD; Hahn A; Illa I; Koski CL; Léger JM; Nobile-Orazio E; Pollard J; Sommer C; Van den Bergh P; van Doorn PA; van Schaik IN Eur J Neurol; 2006 Apr; 13(4):326-32. PubMed ID: 16643309 [TBL] [Abstract][Full Text] [Related]
36. CIDP in a HIV endemic population: A prospective case series from Johannesburg, South Africa. Mochan A; Anderson D; Modi G J Neurol Sci; 2016 Apr; 363():39-42. PubMed ID: 27000218 [TBL] [Abstract][Full Text] [Related]
37. The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach. Créange A; Careyron A; J Neurol; 2013 Dec; 260(12):3015-22. PubMed ID: 24052115 [TBL] [Abstract][Full Text] [Related]
38. The diagnostic value of quantitative assessment of MR neurography in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Chen H; Huang X; Bao Y; Zhao C; Lin J Br J Radiol; 2023 Nov; 96(1151):20221037. PubMed ID: 37393524 [TBL] [Abstract][Full Text] [Related]